Davis Aaron I.'s Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Oct 13, 2022
- Accession no.
- 0000899243-22-033595
- Filed
- Oct 13, 2022, 9:30 PM ET
- Trade date
- Oct 11-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Aaron I.CIK 0001465914 | Director, 10% Owner |
| Lewis JosephCIK 0001015747 | 10% Owner |
| Boxer Asset Management Inc.CIK 0001465836 | 10% Owner |
| Boxer Capital, LLCCIK 0001465837 | 10% Owner |
| MVA Investors, LLCCIK 0001468223 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | Common Stock | PPurchaseAcquired | +117,000 | $4.25F3 | +$497,706.3 | 218,524 | Direct | |
| Oct 12, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $4.43 | +$221,640 | 268,524 | Direct | |
| Oct 13, 2022 | Common Stock | PPurchaseAcquired | +70,000 | $4.65 | +$325,227 | 7,123,642 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects the weighted average sale price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $4.0500 to $4.2631.
Referenced by the price of 1 transaction in Table I.